Cause of death, by non-communicable diseases, ages 15-59 in Algeria
Algeria: Cause of death, by non-communicable diseases, ages 15-59 was 62.8% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 15-59 in Algeria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
Algeria recorded 62.8% for cause of death, by non-communicable diseases, ages 15-59 in 2021.
Compared with earlier readings it is up 35.9% on the previous year and down 5.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Algeria peaked at 71.3% in 2019 and was at its lowest, 46.2%, in 2020.
That places Algeria 62nd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Algeria, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 59.5% | — |
| 2010 | 66.4% | +11.5% |
| 2015 | 67.8% | +2.2% |
| 2019 | 71.3% | +5.1% |
| 2020 | 46.2% | -35.1% |
| 2021 | 62.8% | +35.9% |
Algeria compared with similar countries
- Algeria's 62.8% is above the median for upper middle income countries, which is 53.8%, 1.2× the median. (55 countries reporting)
- Algeria's 62.8% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 52.1%, 1.2× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 59.5% | 59.5% | 59.5% | 1 |
| 2010s | 68.5% | 66.4% | 71.3% | 3 |
| 2020s | 54.5% | 46.2% | 62.8% | 2 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Algeria?
- Cause of death, by non-communicable diseases, ages 15-59 in Algeria was 62.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Algeria?
- The highest recorded value was 71.3% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Algeria?
- The lowest recorded value was 46.2% in 2020.
- How does Algeria rank for cause of death, by non-communicable diseases, ages 15-59?
- Algeria ranks 62nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Algeria?
- Over the last ten years it is down 5.3%. The long-run trend across the full record is flat.
- Where does this Algeria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.